Expert Ratings for Viking Therapeutics
Portfolio Pulse from Benzinga Insights
Viking Therapeutics (NASDAQ:VKTX) has received positive analyst ratings in the last quarter, with 7 bullish and 4 somewhat bullish ratings. The average price target for the stock is $33.36, a significant increase from the current price of $14.4966. This average has increased by 19.14% from the previous average price target of $28.00.
June 27, 2023 | 6:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Viking Therapeutics has received positive analyst ratings, indicating a potential upside for the stock. The average price target has increased by 19.14% from the previous target.
Analyst ratings are a significant factor in stock performance. The positive ratings and increased price target for Viking Therapeutics suggest that analysts are optimistic about the stock's future performance, which could lead to an increase in its price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100